Showing 101 - 120 results of 30,112 for search '(( 2 step decrease ) OR ( 50 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.77s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  7. 107
  8. 108
  9. 109

    The NG50 of ccTSA on datasets from 4 organisms with different sequence coverage and k-mer values. by Jung Ho Ahn (157844)

    Published 2012
    “…The k-mer values were varied from 19 to 35 on 36 bp data and from 37 to 73 on 76 bp data. In most datasets, NG50 values increased then decreased as we increased the k-mer values. …”
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115

    IFNγ increases PRL immunoreactivity in the hair follicle, whilst TNFα decreases follicular PRL immunoreactivity. by Ewan A. Langan (405804)

    Published 2013
    “…Results were pooled from 3 ♀ subjects (Aged 44–68), 14–16 HFs per group in total. In contrast, TNFα 5 ng/ml significantly decreased PRL IR (E). PRL IR is shown in (F) control hair follicles and those treated with (G) TNFα 0.5 ng/ml and (H) TNFα 5 ng/ml. …”
  16. 116
  17. 117
  18. 118
  19. 119

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  20. 120